Brief: Shenzhen Hepalink Pharmaceutical Proposes Offering And Listing Of Hightide Therapeutics
Dec 18 (Reuters) - Shenzhen Hepalink Pharmaceutical
Group Co Ltd 002399.SZ :
* PROPOSED OFFERING AND LISTING OF SHARES OF HIGHTIDE
THERAPEUTICS, INC. ON MAIN BOARD OF STOCK EXCHANGE OF HONG KONG
* AS AT DEC 18, CO IS INTERESTED IN AROUND 24.06% OF TOTAL
ISSUED
SHARE CAPITAL OF HIGHTIDE
Source text for Eikon: ID:
Further company coverage: 002399.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA